Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

What Are the Effects of Irreversible Electroporation on a Staphylococcus aureus Rabbit Model of Osteomyelitis?

Muñoz NM, Minhaj AA, Dupuis CJ, Ensor JE, Golardi N, Jaso JM, Dixon KA, Figueira TA, Galloway-Peña JR, Hill L, Shelburne SA, Tam AL.

Clin Orthop Relat Res. 2019 Aug 5. doi: 10.1097/CORR.0000000000000882. [Epub ahead of print]

PMID:
31393339
2.

Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma.

Muñoz NM, Minhaj AA, Maldonado KL, Kingsley CV, Cortes AC, Taghavi H, Polak U, Mitchell JM, Ensor JE, Bankson JA, Rashid A, Avritscher R.

Magn Reson Imaging. 2019 Apr;57:156-164. doi: 10.1016/j.mri.2018.11.012. Epub 2018 Nov 19.

PMID:
30465870
3.

A molecular dynamics approach towards evaluating osmotic and thermal stress in the extracellular environment.

Fuentes D, Muñoz NM, Guo C, Polak U, Minhaj AA, Allen WJ, Gustin MC, Cressman ENK.

Int J Hyperthermia. 2018;35(1):559-567. doi: 10.1080/02656736.2018.1512161. Epub 2018 Oct 10.

PMID:
30303437
4.

Improved Photoacoustic-Based Oxygen Saturation Estimation With SNR-Regularized Local Fluence Correction.

Naser MA, Sampaio DRT, Munoz NM, Wood CA, Mitcham TM, Stefan W, Sokolov KV, Pavan TZ, Avritscher R, Bouchard RR.

IEEE Trans Med Imaging. 2019 Feb;38(2):561-571. doi: 10.1109/TMI.2018.2867602. Epub 2018 Sep 10.

PMID:
30207951
5.

Development of an Electroporation and Nanoparticle-based Therapeutic Platform for Bone Metastases.

Melancon MP, Appleton Figueira T, Fuentes DT, Tian L, Qiao Y, Gu J, Gagea M, Ensor JE, Muñoz NM, Maldonado KL, Dixon K, McWatters A, Mitchell J, McArthur M, Gupta S, Tam AL.

Radiology. 2018 Jan;286(1):149-157. doi: 10.1148/radiol.2017161721. Epub 2017 Aug 21.

PMID:
28825892
6.

Single cell lineage tracing reveals a role for TgfβR2 in intestinal stem cell dynamics and differentiation.

Fischer JM, Calabrese PP, Miller AJ, Muñoz NM, Grady WM, Shibata D, Liskay RM.

Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12192-12197. Epub 2016 Oct 10.

7.

Vitamin D Deficiency Promotes Liver Tumor Growth in Transforming Growth Factor-β/Smad3-Deficient Mice Through Wnt and Toll-like Receptor 7 Pathway Modulation.

Chen J, Katz LH, Muñoz NM, Gu S, Shin JH, Jogunoori WS, Lee MH, Belkin MD, Kim SB, White JC, Andricovich J, Tzatsos A, Li S, Kim SS, Shetty K, Mishra B, Rashid A, Lee JS, Mishra L.

Sci Rep. 2016 Jul 26;6:30217. doi: 10.1038/srep30217.

8.

A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer.

Rojas A, Zhang P, Wang Y, Foo WC, Muñoz NM, Xiao L, Wang J, Gores GJ, Hung MC, Blechacz B.

Neoplasia. 2016 Jun;18(6):371-86. doi: 10.1016/j.neo.2016.04.002.

9.

TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome.

Chen J, Yao ZX, Chen JS, Gi YJ, Muñoz NM, Kundra S, Herlong HF, Jeong YS, Goltsov A, Ohshiro K, Mistry NA, Zhang J, Su X, Choufani S, Mitra A, Li S, Mishra B, White J, Rashid A, Wang AY, Javle M, Davila M, Michaely P, Weksberg R, Hofstetter WL, Finegold MJ, Shay JW, Machida K, Tsukamoto H, Mishra L.

J Clin Invest. 2016 Feb;126(2):527-42. doi: 10.1172/JCI80937. Epub 2016 Jan 19.

10.

Generation of a mouse model of T-cell lymphoma based on chronic LPS challenge and TGF-β signaling disruption.

Muñoz NM, Katz LH, Shina JH, Gi YJ, Menon VK, Gagea M, Rashid A, Chen J, Mishra L.

Genes Cancer. 2014 Sep;5(9-10):348-352.

11.

Targeting TGF-β signaling in cancer.

Katz LH, Li Y, Chen JS, Muñoz NM, Majumdar A, Chen J, Mishra L.

Expert Opin Ther Targets. 2013 Jul;17(7):743-60. doi: 10.1517/14728222.2013.782287. Epub 2013 May 7. Review.

12.

Mechanical induction of group V phospholipase A(2) causes lung inflammation and acute lung injury.

Meliton AY, Muñoz NM, Meliton LN, Birukova AA, Leff AR, Birukov KG.

Am J Physiol Lung Cell Mol Physiol. 2013 May 15;304(10):L689-700. doi: 10.1152/ajplung.00047.2013. Epub 2013 Mar 22.

13.

Group V phospholipase A(2) increases pulmonary endothelial permeability through direct hydrolysis of the cell membrane.

Muñoz NM, Desai A, Meliton LN, Meliton AY, Zhou T, Leff AR, Dudek SM.

Pulm Circ. 2012 Apr-Jun;2(2):182-92. doi: 10.4103/2045-8932.97604.

14.

Novel reporter systems for facile evaluation of I-SceI-mediated genome editing.

Muñoz NM, Beard BC, Ryu BY, Luche RM, Trobridge GD, Rawlings DJ, Scharenberg AM, Kiem HP.

Nucleic Acids Res. 2012 Jan;40(2):e14. doi: 10.1093/nar/gkr897. Epub 2011 Nov 21.

15.

Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro.

Dudek SM, Muñoz NM, Desai A, Osan CM, Meliton AY, Leff AR.

Am J Respir Cell Mol Biol. 2011 Mar;44(3):361-8. doi: 10.1165/rcmb.2009-0446OC. Epub 2010 May 6.

16.

Cytosolic group IVa phospholipase A2 mediates IL-8/CXCL8-induced transmigration of human polymorphonuclear leukocytes in vitro.

Meliton AY, Muñoz NM, Meliton LN, Binder DC, Osan CM, Zhu X, Dudek SM, Leff AR.

J Inflamm (Lond). 2010 Mar 18;7:14. doi: 10.1186/1476-9255-7-14.

17.

Protection of stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection.

Trobridge GD, Wu RA, Beard BC, Chiu SY, Muñoz NM, von Laer D, Rossi JJ, Kiem HP.

PLoS One. 2009 Nov 2;4(11):e7693. doi: 10.1371/journal.pone.0007693.

18.

Ex vivo expansion and lentiviral transduction of Macaca nemestrina CD4+ T cells.

Muñoz NM, Trobridge GD, Kiem HP.

J Med Primatol. 2009 Dec;38(6):438-43. doi: 10.1111/j.1600-0684.2009.00383.x. Epub 2009 Sep 28.

19.

Leukotriene D4 activates {beta}2-integrin adhesion in human polymorphonuclear leukocytes.

Meliton AY, Muñoz NM, Osan CM, Meliton LN, Leff AR.

Eur Respir J. 2010 Feb;35(2):402-9. doi: 10.1183/09031936.00009309. Epub 2009 Aug 13.

20.

Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice.

Muñoz NM, Meliton AY, Meliton LN, Dudek SM, Leff AR.

Am J Physiol Lung Cell Mol Physiol. 2009 Jun;296(6):L879-87. doi: 10.1152/ajplung.90580.2008. Epub 2009 Mar 13.

21.

TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway.

Trobridge P, Knoblaugh S, Washington MK, Munoz NM, Tsuchiya KD, Rojas A, Song X, Ulrich CM, Sasazuki T, Shirasawa S, Grady WM.

Gastroenterology. 2009 May;136(5):1680-8.e7. doi: 10.1053/j.gastro.2009.01.066. Epub 2009 Feb 4.

22.

TGF-beta has paradoxical and context dependent effects on proliferation and anoikis in human colorectal cancer cell lines.

Muñoz NM, Baek JY, Grady WM.

Growth Factors. 2008 Oct;26(5):254-62. doi: 10.1080/08977190802291667.

23.

Future treatment to lessen exacerbations of chronic obstructive pulmonary disease.

Leff AR, Muñoz NM.

Proc Am Thorac Soc. 2007 Dec;4(8):659-66. Review. Erratum in: Proc Am Thorac Soc. 2008 Feb 15;5(2):283-4.

PMID:
18073398
24.
25.

Blockade of avidity and focal clustering of beta 2-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion.

Meliton AY, Munoz NM, Leff AR.

J Allergy Clin Immunol. 2007 Dec;120(6):1316-23. Epub 2007 Sep 29.

PMID:
17904626
26.

Deletion of secretory group V phospholipase A2 attenuates cell migration and airway hyperresponsiveness in immunosensitized mice.

Muñoz NM, Meliton AY, Arm JP, Bonventre JV, Cho W, Leff AR.

J Immunol. 2007 Oct 1;179(7):4800-7.

27.

Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci.

Veiseh M, Gabikian P, Bahrami SB, Veiseh O, Zhang M, Hackman RC, Ravanpay AC, Stroud MR, Kusuma Y, Hansen SJ, Kwok D, Munoz NM, Sze RW, Grady WM, Greenberg NM, Ellenbogen RG, Olson JM.

Cancer Res. 2007 Jul 15;67(14):6882-8.

29.

Regulation of eosinophil adhesion by lysophosphatidylcholine via a non-store-operated Ca2+ channel.

Zhu X, Learoyd J, Butt S, Zhu L, Usatyuk PV, Natarajan V, Munoz NM, Leff AR.

Am J Respir Cell Mol Biol. 2007 May;36(5):585-93. Epub 2007 Jan 11.

30.

Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.

Muñoz NM, Upton M, Rojas A, Washington MK, Lin L, Chytil A, Sozmen EG, Madison BB, Pozzi A, Moon RT, Moses HL, Grady WM.

Cancer Res. 2006 Oct 15;66(20):9837-44.

31.

Phosphodiesterase 4 inhibition of beta2-integrin adhesion caused by leukotriene B4 and TNF-alpha in human neutrophils.

Meliton AY, Muñoz NM, Lambertino A, Boetticher E, Learoyd J, Zhu X, Leff AR.

Eur Respir J. 2006 Nov;28(5):920-8. Epub 2006 Jun 28.

32.

Transcellular secretion of group V phospholipase A2 from epithelium induces beta 2-integrin-mediated adhesion and synthesis of leukotriene C4 in eosinophils.

Muñoz NM, Meliton AY, Lambertino A, Boetticher E, Learoyd J, Sultan F, Zhu X, Cho W, Leff AR.

J Immunol. 2006 Jul 1;177(1):574-82.

33.

Regulation of interleukin-5-induced beta2-integrin adhesion of human eosinophils by phosphoinositide 3-kinase.

Sano M, Leff AR, Myou S, Boetticher E, Meliton AY, Learoyd J, Lambertino AT, Munoz NM, Zhu X.

Am J Respir Cell Mol Biol. 2005 Jul;33(1):65-70. Epub 2005 Mar 31.

34.

Glucocorticoid-induced surface expression of annexin 1 blocks beta2-integrin adhesion of human eosinophils to intercellular adhesion molecule 1 surrogate protein.

Liu J, Zhu X, Myo S, Lambertino AT, Xu C, Boetticher E, Muñoz NM, Sano M, Cordoba M, Learoyd J, Meliton A, Johnson M, Leff AR.

J Allergy Clin Immunol. 2005 Mar;115(3):493-500.

PMID:
15753895
35.

Beta2-integrin adhesion caused by eotaxin but not IL-5 is blocked by PDE-4 inhibition and beta2-adrenoceptor activation in human eosinophils.

Liu J, Muñoz NM, Meliton AY, Zhu X, Lambertino AT, Xu C, Myo S, Myou S, Boetticher E, Johnson M, Leff AR.

Pulm Pharmacol Ther. 2004;17(2):73-9.

PMID:
15123228
36.

Additive blockade of beta 2-integrin adhesion of eosinophils by salmeterol and fluticasone propionate.

Myo S, Zhu X, Myou S, Meliton AY, Liu J, Boetticher E, Lambertino AT, Xu C, Muñoz NM, Leff AR.

Eur Respir J. 2004 Apr;23(4):511-7.

37.

Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT.

Myou S, Leff AR, Myo S, Boetticher E, Tong J, Meliton AY, Liu J, Munoz NM, Zhu X.

J Exp Med. 2003 Nov 17;198(10):1573-82.

38.

Activation of group IV cytosolic phospholipase A2 in human eosinophils by phosphoinositide 3-kinase through a mitogen-activated protein kinase-independent pathway.

Myou S, Leff AR, Myo S, Boetticher E, Meliton AY, Lambertino AT, Liu J, Xu C, Munoz NM, Zhu X.

J Immunol. 2003 Oct 15;171(8):4399-405.

39.

Blockade of airway inflammation and hyperresponsiveness by HIV-TAT-dominant negative Ras.

Myou S, Zhu X, Myo S, Boetticher E, Meliton AY, Liu J, Munoz NM, Leff AR.

J Immunol. 2003 Oct 15;171(8):4379-84.

40.

Blockade of LTC4 synthesis caused by additive inhibition of gIV-PLA2 phosphorylation: Effect of salmeterol and PDE4 inhibition in human eosinophils.

Meliton AY, Muñoz NM, Liu J, Lambertino AT, Boetticher E, Myo S, Myou S, Zhu X, Johnson M, Leff AR.

J Allergy Clin Immunol. 2003 Aug;112(2):404-10.

PMID:
12897749
41.

Human group V phospholipase A2 induces group IVA phospholipase A2-independent cysteinyl leukotriene synthesis in human eosinophils.

Muñoz NM, Kim YJ, Meliton AY, Kim KP, Han SK, Boetticher E, O'Leary E, Myou S, Zhu X, Bonventre JV, Leff AR, Cho W.

J Biol Chem. 2003 Oct 3;278(40):38813-20. Epub 2003 Jun 9.

42.

IL-5-induced integrin adhesion of human eosinophils caused by ERK1/2-mediated activation of cPLA2.

Zhu X, Jacobs B, Boetticher E, Myou S, Meliton A, Sano H, Lambertino AT, Muñoz NM, Leff AR.

J Leukoc Biol. 2002 Nov;72(5):1046-53.

PMID:
12429728
43.

Regulation of adhesion of AML14.3D10 cells by surface clustering of beta2-integrin caused by ERK-independent activation of cPLA2.

Myou S, Zhu X, Boetticher E, Qin Y, Myo S, Meliton A, Lambertino A, Munoz NM, Hamann KJ, Leff AR.

Immunology. 2002 Sep;107(1):77-85.

44.
45.

Group V phospholipase A2 induces leukotriene biosynthesis in human neutrophils through the activation of group IVA phospholipase A2.

Kim YJ, Kim KP, Han SK, Munoz NM, Zhu X, Sano H, Leff AR, Cho W.

J Biol Chem. 2002 Sep 27;277(39):36479-88. Epub 2002 Jul 17.

46.

Studying human airway pharmacology in microsections: application of videomicrometry.

Schmidt DT, Dent G, Rühlmann E, Muñoz NM, Leff AR, Rabe KF.

Eur Respir J. 2002 Jun;19(6):991-6.

47.

Quantitation of secretory group V phospholipase A(2) in human tissues by sandwich enzyme-linked immunosorbent assay.

Muñoz NM, Boetticher E, Sperling AI, Kim KP, Meliton AY, Zhu X, Lambertino A, Cho W, Leff AR.

J Immunol Methods. 2002 Apr 1;262(1-2):41-51.

PMID:
11983218
48.

Regulation of eosinophil function by phosphatidylinositol-specific PLC and cytosolic PLA(2).

Sano A, Zhu X, Sano H, Muñoz NM, Boetticher E, Leff AR.

Am J Physiol Lung Cell Mol Physiol. 2001 Oct;281(4):L844-51.

49.

Role of mitogen-activated protein kinase-mediated cytosolic phospholipase A2 activation in arachidonic acid metabolism in human eosinophils.

Zhu X, Sano H, Kim KP, Sano A, Boetticher E, Muñoz NM, Cho W, Leff AR.

J Immunol. 2001 Jul 1;167(1):461-8.

50.

Blockade of eosinophil migration and airway hyperresponsiveness by cPLA2-inhibition.

Myou S, Sano H, Fujimura M, Zhu X, Kurashima K, Kita T, Nakao S, Nonomura A, Shioya T, Kim KP, Munoz NM, Cho W, Leff AR.

Nat Immunol. 2001 Feb;2(2):145-9.

PMID:
11175812

Supplemental Content

Loading ...
Support Center